Kommentar Gibt es schon verlässliche Biomarker für Long-COVID?

• Literatur

• 1 Klein J, Wood J, Jaycox JR. et al. Distinguishing features of long COVID identified through immune profiling. Nature 2023; 623: 139-148
• 2 Sullivan KD, Galbraith MD, Kinning KT. et al. The COVIDome Explorer researcher portal. Cell Rep 2021; 36: 109527
• 3 Cervia-Hasler C, Brüningk SC, Hoch T. et al. Persistent complement dysregulation with signs of thromboinflammation in active Long Covid. Science 2024; 383: eadg7942
• 4 Preissner KT, Fischer S. Functions and cellular signaling by ribosomal extracellular RNA (rexRNA): Facts and hypotheses on a non-typical DAMP. Biochim Biophys Acta Mol Cell Res 2023; 1870: 119408
• 5 Burge DJ, Werth VP, Boackle SA. et al. Evaluation of RNase therapy in systemic lupus erythematosus: a randomised phase 2a clinical trial of RSLV-132. Lupus Sci Med 2024; 11: e001113